Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00201019 · ClinicalTrials.gov registry record · NA

Improving Adherence to Blood Pressure Guidelines

A NA study of Hypertension, sponsored by University of Iowa.

Completed
Registry status
NA
Development phase
623
Enrollment target
1
Study location

NCT00201019 is a NA study of Hypertension that has completed, run by University of Iowa. The registered enrollment target is 623 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00201019, a NA study of Hypertension, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
NA
Development phase
623 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

Conditions Studied

Interventions

  • BEHAVIORAL Physician-pharmacist collaborative intervention

Study Locations (1)

Iowa

  • University of Iowa College of Pharmacy - Iowa City

Trial Details

FieldValue
Enrollment Target 623 participants
Start Date 2003-08
Est. Completion 2009-07
Phase NA

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT00201019

The ClinicalTrials.gov registry entry for NCT00201019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 623 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Physician-pharmacist collaborative intervention is the first listed.

NCT00201019 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT00201019 about?

NCT00201019 is a clinical study titled "Improving Adherence to Blood Pressure Guidelines". The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

What is the current status of trial NCT00201019?

This trial is currently completed. It is a NA study. The enrollment target is 623 participants. The study started on 2003-08. Estimated completion is 2009-07.

What conditions does trial NCT00201019 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00201019?

The interventions under investigation include: Physician-pharmacist collaborative intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00201019?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00201019 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.